Role of chromosome 1 pericentric heterochromatin (1q) in pathogenesis of myelodysplastic syndromes: Report of 2 new cases

Experimental and Molecular Pathology

Volumn 84, Issue 2, 2008, Pages 189-193

  Millington, Karmaine ^a   Hudnall, S David ^a   Northup, Jill ^a   Panova, Neli ^a   Velagaleti, Gopalrao ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

1q heterochromatin; Clonal abnormalities; Epigenetic control; MDS

Indexed keywords

ANTIBIOTIC AGENT; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD CELL COUNT; BLOOD TRANSFUSION; BONE MARROW BIOPSY; BONE MARROW DEPRESSION; CASE REPORT; CELL LINEAGE; CHROMOSOME 1Q; CHROMOSOME ANALYSIS; CLINICAL FEATURE; DISEASE ASSOCIATION; EUCHROMATIN; FEMALE; FOLLOW UP; GENE DOSAGE; HETEROCHROMATIN; HUMAN; HUMAN CELL; HYPOPROLIFERATIVE ANEMIA; LABORATORY TEST; MONOSOMY; MONOSOMY 7; MULTIPLE MYELOMA; MYELODYSPLASIA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PHYSICAL EXAMINATION; THROMBOCYTOPENIA; TRISOMY; TRISOMY 8;

AGED; BLOOD CELL COUNT; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CLONE CELLS; FATAL OUTCOME; FEMALE; HETEROCHROMATIN; HUMANS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEUTROPHILS; SPECTRAL KARYOTYPING; TREATMENT OUTCOME;

EID: 40949101673     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2007.10.003     Document Type: Article

References (16)

1. Aten J.A., Stap J., Krawczyk P.M., van Oven C.H., Hoebe R.A., Essers J., and Kanaar R. Dynamics of DNA double-strand breaks revealed by clustering of damaged chromosome domains. Science 303 (2004) 92-95
2. Baccon P.L., Leroux D., Dascalescu C., Duley S., Marais D., Esmenjaud E., Sotto J.J., and Callanan M. Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma. Genes Chromosomes Cancer 32 (2001) 250-264
3. Barki-Celli L., Lefebvre C., Baccon P.L., Nadeau G., Bonnefoix T., Usson Y., Vourc'h C., Khochbin S., Leroux D., and Callanan M. Differences in nuclear positioning of 1q12 pericentric heterochromatin in normal and tumor B lymphocytes with 1q rearrangements. Genes Chromosomes Cancer 43 (2005) 339-349
4. Catenacci D.V.T., and Schiller G.J. Myelodysplastic syndromes: a comprehensive review. Blood Rev. 19 (2005) 301-319
5. Cooke H.J., and Hindley J. Cloning of human satellite III DNA: different components are on different chromosomes. Nucleic Acids Res. 6 (1979) 3177-3197
6. Horiike S., Taniwaki M., Misawa S., and Abe T. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer 62 (1988) 1129-1138
7. ISCN. An International System for Human Cytogenetic Nomenclature. In: Shaffer L.G., and Tommerup N. (Eds) (2005), S. Karger, Basel
8. Keung Y.-K., Cobos E., Tonk V., and Morgan D. Translocation (1;22) in refractory anemia and the prognostic significance of karyotypic abnormalities in refractory anemia. Cancer Genetics Cytogenet 106 (1998) 72-75
9. Lee D.S., Kim S.H., Seo E.J., Park C.J., Chi H.S., Ko E.K., Yoon B.H., Kim W.H., and Cho H.I. Predominance of trisomy 1q in myelodysplastic syndromes in Korea: is there an ethnic difference? A 3-year multi-center study. Cancer Genet. Cytogenet. 132 (2002) 97-101
10. Mecucci C., Van Orshoven A., Vermaelen K., Michaux J.L., Tricot G., Louwagie A., Delannoy A., and Van den Berghe H. 11q-chromosome is associated with abnormal iron stores in myelodysplastic syndrome. Cancer Genet. Cytogenet. 27 (1987) 39-44
11. Morerio C., Rapella A., Tassano E., Lanino E., Micalizzi C., Rosanda C., and Panarello C. Gain of 1q in pediatric myelodysplastic syndromes. Leuk. Res. 30 (2006) 1437-1441
12. Odish O.F.F., Gotoh A., Liu Y.-C., Shoji N., Kimura Y., Kodama A., and Ohyashiki K. Recurrent unbalanced whole arm t(1;10)(q10;p10) in myelodysplastic syndrome: a case report and literature review. Cancer Genet. Cytogenet. 172 (2007) 165-167
13. Sakai C., Matsubayashi K., Saotome T., Ishii A., and Kumagai K. Therapy-related myelodysplastic syndrome with trisomy 1q due to der(1;7) and megakaryoblastic proliferation developing during complete remission of therapy-related acute myeloid leukemia with t(8;21). Intern. Med. 43 (2004) 582-586
14. Sole F., Espinet B., Sanz G.F., Cervera J., Calasanz M.J., Luno E., Prieto F., Granada I., Hernandez J.M., Cigudosa J.C., Diez J.L., Bureo E., Marques M.L., Arranz E., Rios R., Martinez Climent J.A., Vallespi T., Florensa L., and Woessner S. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica hematological. Br. J. Haematol. 108 (2000) 346-356
15. Surrales J., Darroudi F., and Natarajan A. Low level of DNA repair in human chromosome 1 heterochromatin. Genes Chromosomes Cancer 20 (1997) 173-184
16. Wang L., Ogawa S., Hangaishi A., Qiao Y., Hosoya N., Nanya Y., Ohyashiki K., Mizoguchi H., and Hirai H. Molecular characterization of the recurrent unbalanced translocation der(1;7)(q10;p10). Blood 102 (2003) 2597-2604